Drug Name |
Ticagrelor
|
||
Synonyms |
Ticagrelor; 274693-27-5; Brilique; AZD-6140; AZD6140; AZD 6140; AR-C126532XX; UNII-GLH0314RVC; [14C]-Ticagrelor; GLH0314RVC; CHEBI:68558; (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPYL]AMINO]-5-(PROPYLTHIO)-3H-1,2,3-TRIAZOLO[4,5-D]PYRIMIDIN-3-YL]-5-(2-HYDROXYETHOXY)-1,2-CYCLOPENTANEDIOL; (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol; Brilique; AR-C126532; Ticagrelor (USAN/INN); Brilinta/Brilique
|
||
Drug Type |
Small molecular drug
|
||
Company |
AstraZeneca
|
||
Summary |
Ticagrelor is a P2Y12 platelet inhibitor used in patients with a history of myocardial infarction or with acute coronary syndrome (ACS) to prevent future myocardial infarction, stroke and cardiovascular death.
|
![]() |
Formula |
C23H28F2N6O4S
|
Canonical SMILES |
CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F
|
|
InChI |
1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
|
|
InChIKey |
OEKWJQXRCDYSHL-FNOIDJSQSA-N
|
|
CAS Number | CAS 274693-27-5 | |
TTD ID | D0WF7L | |
DrugBank ID | DB08816 | |
PubChem Compound ID | 9871419 | |
PubChem Substance ID |
14836432
,
14860737
,
24162024
,
45293678
,
49684205
,
57373617
,
77877844
,
92729712
,
96025700
,
103554312
,
123051091
,
124759706
,
126644885
,
126666051
,
135649975
,
136345665
,
137171656
,
139857160
,
152040158
,
152258075
,
160645837
,
160646914
,
162011636
,
163346229
,
163383616
,
164178089
,
164765598
,
165245536
,
170501033
,
171063069
,
172914585
,
174528632
,
175267325
,
175427101
,
185974765
,
189657701
,
198993342
,
211534943
,
223384813
,
223666650
,
224638556
,
228139491
,
247988848
,
249582784
,
249807649
,
249807650
,
249816423
,
251966736
,
251970939
,
252216468
|
|
ChEBI ID | CHEBI:68558 | |
ADReCS Drug ID | BADD_D02214 |
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |